Hair loss in women.

Hair loss in women is a very common clinical complaint, and is usually associated with severe emotional distress. In this article, the authors review the most common clinical causes of hair loss in women, and emphasize the role of hormonal changes in the regulation of hair loss and hair growth.

[1]  N. Balamtekin,et al.  The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid , 2009, Brain and Development.

[2]  S. Shrivastava.  Diffuse hair loss in an adult female: approach to diagnosis and management. , 2009, Indian journal of dermatology, venereology and leprology.

[3]  V. Randall.  The Endocrine Control of the Hair Follicle , 2008 .

[4]  G. Panfilis,et al.  Familial Uncombable Hair Syndrome: Ultrastructural Hair Study and Response to Biotin , 2007, Pediatric dermatology.

[5]  S. Harrap,et al.  Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia , 2007, Human Genetics.

[6]  V. Sehgal,et al.  Trichotillomania ± trichobezoar: revisited , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  A. Tosti,et al.  Alopecia areata: a long term follow-up study of 191 patients. , 2006, Journal of the American Academy of Dermatology.

[8]  S. Nakagawa,et al.  A Comparison of the Efficacy, Relapse Rate and Side Effects among Three Modalities of Systemic Corticosteroid Therapy for Alopecia Areata , 2006, Dermatology.

[9]  W. Bergfeld,et al.  The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. , 2006, Journal of the American Academy of Dermatology.

[10]  M. Hordinsky.  Medical treatment of noncicatricial alopecia. , 2006, Seminars in cutaneous medicine and surgery.

[11]  M. P. Birch,et al.  Female pattern hair loss, sebum excretion and the end‐organ response to androgens , 2006, The British journal of dermatology.

[12]  P. Arck,et al.  Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control , 2006, Experimental dermatology.

[13]  W. Breed,et al.  Prevention of chemotherapy-induced hair loss by scalp cooling. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  P. Arck,et al.  Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. , 2004, The Journal of investigative dermatology.

[15]  D. Piacquadio,et al.  A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. , 2004, Journal of the American Academy of Dermatology.

[16]  G. Keating,et al.  Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. , 2004, Drugs.

[17]  G. Cotsarelis,et al.  Decreased serum ferritin is associated with alopecia in women. , 2003, The Journal of investigative dermatology.

[18]  J. Nissimov,et al.  Scalp hair diameter increases during pregnancy , 2003, Clinical and experimental dermatology.

[19]  B. Piraccini,et al.  Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. , 2003, Journal of the American Academy of Dermatology.

[20]  B. Klapp,et al.  Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. , 2003, The American journal of pathology.

[21]  J. Grant-Kels,et al.  Approach to the adult female patient with diffuse nonscarring alopecia. , 2002, Journal of the American Academy of Dermatology.

[22]  R. Sinclair.  There is no clear association between low serum ferritin and chronic diffuse telogen hair loss , 2002 .

[23]  E. Olsen,et al.  A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. , 2002, Journal of the American Academy of Dermatology.

[24]  D. Mock,et al.  Marginal biotin deficiency during normal pregnancy. , 2002, The American journal of clinical nutrition.

[25]  A. Faúndes,et al.  Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials. , 2002, Contraception.

[26]  T. Pringle.  The relationship between thyroxine, oestradiol, and postnatal alopecia, with relevance to women's health in general. , 2000, Medical hypotheses.

[27]  A. Tosti,et al.  Management of androgenetic alopecia ★ , 1999, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  E. Phillips,et al.  Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States. , 1997, Clinical therapeutics.

[29]  A. Kauschansky,et al.  Hair loss in children on long-acting gonadotropin-releasing hormone agonist triptorelin treatment. , 1997, Acta dermato-venereologica.

[30]  C. Gateley,et al.  Alopecia and breast disease , 1997, BMJ.

[31]  D. Whiting,et al.  Chronic telogen effluvium. , 1996, Dermatologic clinics.

[32]  G. Hortobagyi,et al.  A randomized trial of minoxidil in chemotherapy-induced alopecia. , 1996, Journal of the American Academy of Dermatology.

[33]  J. Headington.  Telogen effluvium. New concepts and review. , 1993, Archives of dermatology.

[34]  W. Nyhan.  Inborn errors of biotin metabolism. , 1987, Archives of dermatology.

[35]  W. Shelley,et al.  Uncombable hair syndrome: observations on response to biotin and occurrence in siblings with ectodermal dysplasia. , 1985, Journal of the American Academy of Dermatology.

[36]  L. Goldsmith.  Vitamins and alopecia. , 1980, Archives of dermatology.

[37]  Y. Lynfield.  Effect of pregnancy on the human hair cycle. , 1960, The Journal of investigative dermatology.